Ad
related to: dabigatran approved for stroke victims in illinois today news channel
Search results
Results from the WOW.Com Content Network
In October 2010 the US FDA approved dabigatran etexilate for the prevention of stroke in patients with atrial fibrillation (AF). [ 6 ] [ 10 ] Many pharmaceutical companies have attempted to develop orally bioavailable DTI drugs but dabigatran etexilate is the only one to reach the market.
Dabigatran, sold under the brand name Pradaxa among others, is an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. [ 6 ] [ 7 ] Specifically it is used to prevent blood clots following hip or knee replacement and in those with a history of prior clots. [ 6 ]
The Daily Eastern News – Eastern Illinois University The Daily Egyptian – Southern Illinois University Carbondale The Daily Illini – University of Illinois at Urbana–Champaign
A jury in the Circuit Court of Cook County has awarded $41 million to a 72-year-old lawyer whose cerebral artery stroke was brought on by medical mismanagement at the Peoria-based OSF HealthCare ...
The beginnings of the stroke serve as a reminder of what symptoms to look out for.
The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in ...
[4] [5] [6] They are commonly prescribed to treat and prevent blood clots in veins, prevent stroke and embolism in people with non-valvular atrial fibrillation (AF) who have other risk factors, and prevent blood clots after routine knee and hip replacement surgery. [2] [3] [7]
For premium support please call: 800-290-4726 more ways to reach us
Ad
related to: dabigatran approved for stroke victims in illinois today news channel